I sit down with Alison Bateman-House, PhD, MPH, MA, from NYU, to discuss the details of the “Right To Try Act” a year after it was signed into law. Was it a good idea? Do patients stand to benefit? What led to this initiative and how does this help clinical trial enrollment, if at all?
If you have any interest in healthcare policy and how it might affect patient care and healthcare delivery, this episode is for you.